Izraelis - anglų - Ministry of Health

takeda israel ltd - albumin human - solution for infusion - albumin human 200 mg / 1 ml - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate.

Izraelis - anglų - Ministry of Health

takeda israel ltd - albumin human - solution for infusion - albumin human 50 mg / 1 ml - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate.

Kanada - anglų - Health Canada

cutter med & biol, division of miles canada ltd. - albumin - liquid - 50mg - albumin 50mg - blood derivatives

Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxalta innovations gmbh - albumin human 50 g/l - solution for infusion - 50 g/l - albumin human 50 mg/ml - albumin

Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin

Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin

Kanada - anglų - Health Canada

baxter ag - albumin (human) - solution - 5% - albumin (human) 5% - blood derivatives

Kanada - anglų - Health Canada

baxter ag - albumin (human) - solution - 25% - albumin (human) 25% - blood derivatives

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

takeda pharmaceuticals america, inc. - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 0.05 g in 1 ml - flexbumin 5% [albumin (human)] is indicated for hypovolemia, hypoalbuminemia and cardiopulmonary bypass surgery. flexbumin 5% [albumin (human)] is indicated for reversing hypovolemia. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 25% albumin should be used.4,6 flexbumin 5% is indicated for patients with hypoalbuminemia resulting from one or more of the following:5 flexbumin 5% is indicated for patients with hypoalbuminemia accompanying severe injuries, infections or severe pancreatitis that cannot be quickly reversed and nutritional supplements fail to restore serum albumin levels. burns after the first 24 hours, flexbumin 5% is indicated in conjunction with appropriate crystalloid therapy, for the treatment of oncotic deficits following extensive burns and to replace protein loss which accompanies any severe burn.4,6 preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass surgery. flexbumin 5% is indicated a

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

takeda pharmaceuticals america, inc. - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 0.20 g in 1 ml - flexbumin 20% [albumin (human)] is indicated for hypovolemia, hypoalbuminemia, cardiopulmonary bypass surgery, and hemolytic disease of the newborn (hdn). flexbumin 20% [albumin (human)] is indicated for reversing hypovolemia. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% albumin should be used.4,6 flexbumin 20% is indicated for patients with hypoalbuminemia resulting from one or more of the following:5 flexbumin 20% is indicated for patients with hypoalbuminemia accompanying severe injuries, infections or severe pancreatitis that cannot be quickly reversed and nutritional supplements fail to restore serum albumin levels. burns after the first 24 hours, flexbumin 20% is indicated, in conjunction with appropriate crystalloid therapy, for the treatment of oncotic deficits following extensive burns and to replace the protein loss which accompanies any severe burn.4,6 adult respiratory distress syndrome (ards) flexbumin 20% is indicated, in conjunctio